Nick Traggis

Nick Traggis is an accomplished entrepreneur and executive with extensive experience in drug discovery and diagnostics as the Founder and President of Ambrosia Biosciences Inc., focused on developing small molecule-based therapies for obesity and metabolic disorders. Traggis has held significant leadership roles, including Chief Executive Officer of LightDeck Diagnostics, where successful fundraising efforts led to its sale to Heska Corporation. Other notable positions include strategic advisor roles at various companies and a member of boards of directors for different organizations. With a strong background in engineering and product development, Traggis has a proven track record of driving growth and innovation across multiple industries, including biotechnology, medical devices, and manufacturing. Traggis holds a B.S. in Materials Science from the Colorado School of Mines.